Newcomer PACAP could make the difference in migraine control
<p>Anti-CGRP therapy has dramatically improved migraine treatment for many patients since its introduction in 2018. However, 30–40% of patients do not respond adequately to these drugs. Prof. Messoud Ashina talks to us about PACAP and why targeting this pathway could offer a new future option for such patients. </p>

Newcomer PACAP could make the difference in migraine control Anti-CGRP therapy has dramatically improved migraine treatment for many patients since its introduction in 2018. However, 30–40% of patients do not respond adequately to these drugs. Prof. Messoud Ashina talks to us about PACAP and why targeting this pathway could offer a new future option for such patients.

Episode 21: Moving towards migraine freedom?

Medicine Matters is a pan-specialty podcast for doctors, that discusses the most exciting, controversial, and practice-changing topics across medical practice as a whole. In our episodes, we’ll be talking to leading clinical experts, to researchers and funding institutes, and to industry partners about the well-known and perhaps the lesser-known issues affecting doctors in their clinics. We’ll be looking at everything from new drug approvals to social issues affecting medicine, and we’ll be challenging some of the status quo along the way.

Share Episode 21: Moving towards migraine freedom?

Sign up to save your podcasts

Episode 21: Moving towards migraine freedom?

Episode 21: Moving towards migraine freedom?